Real-life data on the efficacy and safety of letermovir for cytomegalovirus prophylaxis in high-risk pediatric patients: a single-center analysis.

Prevymis (letermovir) - Merck (MSD)

http://www.ncbi.nlm.nih.gov/pubmed/40949906

Chenguang Jia; Guanghua Zhu; Jie Zheng; Jun Yang; Lixiao Cai; Maoquan Qin; Meng Zhang; Ningning Chen; Pan Zhang; Wei Yang; Yanhui Luo; Yuanfang Jing

Sep 16, 2025